Lung function measurements in children - copsac
Lung function measurements in children - copsac
Lung function measurements in children - copsac
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
detection changes <strong>in</strong> lung <strong>function</strong> (dose-response curve metachol<strong>in</strong>e challenge),<br />
followed by FEV 0.5 , both superior to other <strong>in</strong>dexes of forced spirometry as well as all<br />
tidal breath<strong>in</strong>g <strong>in</strong>dexes (10, 133); therefore we only report these two parameters <strong>in</strong> this<br />
study. A shorter time limit as 0.4 s may have improved the sensitivity (185). Values of<br />
FEF% have been reported to be more discrim<strong>in</strong>ative than FEV(t) <strong>in</strong> some studies (186).<br />
The discrepant f<strong>in</strong>d<strong>in</strong>g could be due to the different def<strong>in</strong>ition of sensitivity. In our<br />
previous study the sensitivity was def<strong>in</strong>ed as the ability to detect <strong>in</strong>duced changes <strong>in</strong><br />
lung <strong>function</strong> with<strong>in</strong> an <strong>in</strong>dividual while <strong>in</strong> other studies it was def<strong>in</strong>ed as the ability to<br />
discrim<strong>in</strong>ate between disease and healthy <strong>in</strong>fants. An Australian study showed that<br />
FEV(t) were more reproducible than flow <strong>measurements</strong> <strong>in</strong> the tidal volume range and<br />
also found that FEV(t) were significantly lower <strong>in</strong> wheezy <strong>in</strong>fants with less overlap than<br />
flow <strong>measurements</strong> (187).<br />
The coefficient of variation for PtcO 2 and FEV 0.5 were 4% and 7% respectively based<br />
on <strong>measurements</strong> before and after sal<strong>in</strong>e solution <strong>in</strong>halation. RVRTC-<strong>measurements</strong><br />
were automatically registered, and results from PtcO 2 were read from the pr<strong>in</strong>t-outs by<br />
an <strong>in</strong>dependent person, different from the operators. Volume-time curves were only<br />
accepted if the forced expiration proceeded smoothly, with no signs of glottic closure or<br />
early <strong>in</strong>spiration. The software def<strong>in</strong>ed FVC as the first plateau on the volume-time<br />
curve, and only <strong>measurements</strong> with FVC appear<strong>in</strong>g after 0.5 seconds, and with FEV 0.5<br />
be<strong>in</strong>g smaller than or equal to FVC were accepted. In addition, FVC was only accepted<br />
if correctly def<strong>in</strong>ed as the plateau appear<strong>in</strong>g after a full expiration. The curve conta<strong>in</strong><strong>in</strong>g<br />
the median value for the FEV 0.5 was used for the analyses of both volume and flow<br />
parameters (133). The choice of “best” trial differs <strong>in</strong> this study from the ATS/ERS<br />
guidel<strong>in</strong>es which recommend choos<strong>in</strong>g the “best” (technically) trial def<strong>in</strong>ed as the one<br />
with either the highest sum of FVC and FEV 0.4/0.5 or FEF 25-75 , provided they are with<strong>in</strong><br />
10% of the next best loop (2).<br />
We analyzed bronchial responsiveness as a quantitative trait <strong>in</strong> the RSV and control<br />
group rather than dichotomiz<strong>in</strong>g the <strong>in</strong>fants <strong>in</strong>to +/- hyperresponsiveness.<br />
All cases of non-RSV bronchiolitis and acute severe wheeze episodes were excluded<br />
from the control group, which would tend to favor a difference between our cases and<br />
controls. We made a spot check <strong>in</strong> the control group and found no acute wheeze<br />
episodes <strong>in</strong> their hospital records. 44 <strong>children</strong> <strong>in</strong> the control group dropped out before<br />
48